Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Non-cash Items (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Non-cash Items for 5 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items changed N/A to $9.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $9.3 million for FY2025, 18.77% up from the prior year.
  • Non-cash Items for Q4 2025 was $9.3 million at Relay Therapeutics, down from $18.9 million in the prior quarter.
  • The five-year high for Non-cash Items was $45.9 million in Q4 2021, with the low at $9.3 million in Q4 2025.
  • Average Non-cash Items over 4 years is $27.2 million, with a median of $26.8 million recorded in 2022.
  • The sharpest move saw Non-cash Items fell 24.54% in 2022, then plummeted 45.43% in 2023.
  • Over 4 years, Non-cash Items stood at $45.9 million in 2021, then dropped by 24.54% to $34.6 million in 2022, then tumbled by 45.43% to $18.9 million in 2023, then tumbled by 50.64% to $9.3 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $9.3 million, $18.9 million, and $34.6 million for Q4 2025, Q4 2023, and Q4 2022 respectively.